January 13, 2026

Arcutis Biotherapeutics, Inc. (ARQT): Investor Outlook Reveals 18% Upside Potential

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is attracting significant attention in the biotechnology sector, with its robust pipeline of dermatology-focused treatments and a promising 18.09% upside based..

MoonLake Immunotherapeutics (MLTX): Navigating the Ups and Downs of a Volatile Biotech Stock

MoonLake Immunotherapeutics (NASDAQ: MLTX), a Swiss-based biotechnology company, is carving a niche in the healthcare sector with its innovative approach to treating inflammatory skin and joint..

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring the 563.16% ROE and Future Potential

Bausch Health Companies Inc. (NYSE: BHC) is a key player in the healthcare sector, operating within the drug manufacturers – specialty and generic industry. Headquartered in..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Potential Upside Amidst Biotechnology Challenges

Recursion Pharmaceuticals, Inc. (RXRX), a burgeoning name in the biotechnology sector, has piqued the interest of investors with its innovative approach to drug discovery, despite recent..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: 15.85% Potential Upside with Strong Buy Ratings

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) has captured the attention of investors with its impressive growth potential and a robust product pipeline in the eye care sector...

SS Innovations International (SSII) Stock Analysis: Unpacking a 192.5% Revenue Surge in the Healthcare Device Sector

SS Innovations International, Inc. (SSII) is capturing attention in the healthcare sector with its remarkable 192.5% revenue growth, a standout figure in the medical devices industry...

Merus N.V. (MRUS) Stock Analysis: Healthcare Innovator with 7.78% Upside Potential

Merus N.V. (NASDAQ: MRUS), a pioneering force in the biotechnology sector, is making waves with its innovative approach to immuno-oncology. Headquartered in Utrecht, the Netherlands, this..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Expert Ratings Signal Robust 78.16% Upside Potential

Centessa Pharmaceuticals plc (NASDAQ: CNTA) is making waves in the biotech sector with its strong potential for growth, underscored by an impressive analyst rating. With a..

Zai Lab Limited (ZLAB) Stock Analysis: Potential 161% Upside Amid Strong Buy Consensus

Zai Lab Limited (NASDAQ: ZLAB) presents a compelling opportunity for investors seeking exposure to the rapidly evolving biotechnology sector. With a solid market capitalization of $2.04..

Biohaven Ltd. (BHVN) Investor Outlook: Navigating Opportunities with a 68% Upside Potential

Biohaven Ltd. (NASDAQ: BHVN), a prominent player in the biotechnology industry, has been capturing investor attention with its innovative approach in developing therapies across immunology, neuroscience,..

Edgewise Therapeutics (EWTX) Stock Analysis: A 58% Upside Potential in the Biotech Sector

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a burgeoning player in the biotechnology industry, has captured investor attention with an enticing potential upside of 58.17%. This biopharmaceutical company,..

Organon & Co. (OGN) Stock Analysis: Exploring a 15% Potential Upside Amidst Diverse Product Portfolio

Organon & Co. (OGN), a prominent player in the healthcare sector, operates within the drug manufacturing industry, offering a wide range of health solutions through prescription..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotech Innovator with a 13% Potential Upside

Scholar Rock Holding Corporation (NASDAQ: SRRK), a Cambridge-based biopharmaceutical company, is making headlines with its innovative approach in the biotechnology sector. Focusing on the discovery and..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Navigating a Path with a 20% Upside Potential

Tandem Diabetes Care, Inc. (TNDM) stands as a significant player in the healthcare sector, specifically within the medical devices industry. Headquartered in San Diego, California, Tandem..

Sotera Health Company (SHC) Stock Analysis: Strong Buy Ratings and 7.68% Potential Upside

Sotera Health Company (NASDAQ: SHC) is drawing attention from investors with a strong buy consensus and a promising potential upside. As a leading player in the..

CONMED Corporation (CNMD) Stock Analysis: A Look at Healthcare’s Undervalued Player with 11% Upside Potential

CONMED Corporation (NASDAQ: CNMD), a key player in the medical devices sector, stands as an intriguing prospect for investors seeking exposure in the healthcare industry. With..

Envista Holdings Corporation (NVST) Stock Analysis: A Healthcare Player with a Mixed Growth Outlook

Envista Holdings Corporation (NYSE: NVST) is an intriguing entity in the healthcare sector, focusing on the medical instruments and supplies industry. As of the latest data,..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Evaluating a 10.28% Potential Upside for Investors

Guardian Pharmacy Services, Inc. (GRDN), a pivotal player in the healthcare sector, specifically within the medical care facilities industry, is capturing the attention of investors with..

Harmony Biosciences Holdings (HRMY) Stock Analysis: Strong Growth, Attractive Valuation, and Promising Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a prominent player in the biotechnology sector, is catching the eye of investors with its robust growth trajectory and promising..

GeneDx Holdings Corp. (WGS) Stock Analysis: Evaluating the 43.32% Potential Upside in the Genomic Sector

GeneDx Holdings Corp. (NASDAQ: WGS) stands at the intersection of cutting-edge genomics and diagnostics, carving a niche in the healthcare industry with its pioneering genetic testing..

Search

Funds

January 13, 2026

Search

Funds

January 13, 2026

FTSE 100

Funds